Amgen sales and marketing update

Amgen launched leukemia drug Blincyto blinatumomab. Blincyto has a wholesale acquisition cost (WAC)

Read the full 136 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE